Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Semin Dial ; 32(4): 291-296, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-30970389

RESUMEN

Clinical manifestations of functional and morphological muscular abnormalities in dialysis patients are muscle weakness and low exercise capacity, possibly leading to a sedentary life style with low physical activity. Low cardiorespiratory fitness and muscle atrophy and weakness contribute to the development of frailty and affect patients' ability to physically navigate their environment. While many dialysis patients may appear too frail to participate in moderate-to-vigorous aerobic exercise training, those who can complete such programs appear to derive substantial benefit. Less vigorous aerobic exercise, resistance training, and alternative forms of exercise can also be beneficial. Most patients on dialysis are not too frail to perform resistance exercise of adequate intensity to achieve increases in muscle size and strength, therefore, frailty should not be considered a contraindication to exercise.


Asunto(s)
Ejercicio Físico/fisiología , Debilidad Muscular/rehabilitación , Calidad de Vida , Diálisis Renal/efectos adversos , Entrenamiento de Fuerza/métodos , Anciano , Anciano de 80 o más Años , Tolerancia al Ejercicio , Femenino , Fragilidad , Humanos , Fallo Renal Crónico/diagnóstico , Fallo Renal Crónico/terapia , Masculino , Persona de Mediana Edad , Debilidad Muscular/etiología , Diálisis Renal/métodos , Medición de Riesgo , Resultado del Tratamiento
2.
Kidney Int ; 84(1): 45-53, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23423255

RESUMEN

Although water is essential for life, its use for medicinal purposes is not universally accepted. We performed a comprehensive review of the literature to determine where the evolving state of knowledge lies regarding the benefits of water as a therapy for renal diseases. In the past two decades, water has emerged as a potential therapeutic agent in nephrolithiasis, chronic kidney disease (CKD), and polycystic kidney disease (PKD) in particular. In nephrolithiasis, the benefit of drinking water beyond that demanded by thirst is a cornerstone of therapy for both primary and secondary disease. In CKD, recent observational studies suggest a strong, direct association between preservation of renal function and fluid intake. In PKD, increased water intake slows renal cyst growth in animals via direct vasopressin suppression, and pharmacologic blockade of renal vasopressin-V2 receptors has recently been shown to be efficacious in retarding cyst growth in PKD patients. Although evidence is lacking to support increased water intake in the general population, available evidence indicates that individuals who are at risk for nephrolithiasis as well as those with CKD and PKD may benefit from 3 to 4 l of urine output each day, a level of excretion that is likely to be safe.


Asunto(s)
Ingestión de Líquidos , Fluidoterapia , Enfermedades Renales/terapia , Riñón/fisiopatología , Equilibrio Hidroelectrolítico , Fluidoterapia/efectos adversos , Humanos , Enfermedades Renales/diagnóstico , Enfermedades Renales/fisiopatología , Nefrolitiasis/fisiopatología , Nefrolitiasis/terapia , Enfermedades Renales Poliquísticas/fisiopatología , Enfermedades Renales Poliquísticas/terapia , Insuficiencia Renal Crónica/fisiopatología , Insuficiencia Renal Crónica/terapia , Factores de Riesgo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA